| Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion AC Bellail, SB Hunter, DJ Brat, C Tan, EG Van Meir The international journal of biochemistry & cell biology 36 (6), 1046-1069, 2004 | 642 | 2004 |
| A direct cell quenching method for cell-culture based metabolomics Q Teng, W Huang, TW Collette, DR Ekman, C Tan Metabolomics 5, 199-208, 2009 | 240 | 2009 |
| Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway C Tan, RG de Noronha, AJ Roecker, B Pyrzynska, F Khwaja, Z Zhang, ... Cancer research 65 (2), 605-612, 2005 | 223 | 2005 |
| Genetic and hypoxic regulation of angiogenesis in gliomas B Kaur, C Tan, DJ Brat, EG Van Meir Journal of neuro-oncology 70, 229-243, 2004 | 208 | 2004 |
| Proteasome inhibitor PS-341, a potential therapeutic agent for adult T-cell leukemia C Tan, TA Waldmann Cancer research 62 (4), 1083-1086, 2002 | 199 | 2002 |
| Combination of microRNA therapeutics with small-molecule anticancer drugs: mechanism of action and co-delivery nanocarriers X Dai, C Tan Advanced drug delivery reviews 81, 184-197, 2015 | 143 | 2015 |
| Exploiting exosomes in cancer liquid biopsies and drug delivery CA Fitts, N Ji, Y Li, C Tan Advanced healthcare materials 8 (6), 1801268, 2019 | 112 | 2019 |
| Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis V Kumar, X Xin, J Ma, C Tan, N Osna, RI Mahato Advanced drug delivery reviews 176, 113888, 2021 | 75 | 2021 |
| Exploring polymeric micelles for improved delivery of anticancer agents: recent developments in preclinical studies C Tan, Y Wang, W Fan Pharmaceutics 5 (1), 201-219, 2013 | 73 | 2013 |
| Enhanced tumor delivery of gemcitabine via PEG-DSPE/TPGS mixed micelles Y Wang, W Fan, X Dai, U Katragadda, DA Mckinley, Q Teng, C Tan Molecular pharmaceutics 11 (4), 1140-1150, 2014 | 69 | 2014 |
| Design and in Vitro Activities of N-Alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, Novel, Small-Molecule Hypoxia Inducible Factor-1 … J Mun, AA Jabbar, NS Devi, S Yin, Y Wang, C Tan, D Culver, JP Snyder, ... Journal of medicinal chemistry 55 (15), 6738-6750, 2012 | 68 | 2012 |
| Multi-drug delivery to tumor cells via micellar nanocarriers U Katragadda, Q Teng, BM Rayaprolu, T Chandran, C Tan International journal of pharmaceutics 419 (1-2), 281-286, 2011 | 65 | 2011 |
| BAI1 suppresses medulloblastoma formation by protecting p53 from Mdm2-mediated degradation D Zhu, S Osuka, Z Zhang, ZR Reichert, L Yang, Y Kanemura, Y Jiang, ... Cancer cell 33 (6), 1004-1016. e5, 2018 | 60 | 2018 |
| Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG) T Chandran, U Katragadda, Q Teng, C Tan International journal of pharmaceutics 392 (1-2), 170-177, 2010 | 56 | 2010 |
| Combined delivery of paclitaxel and tanespimycin via micellar nanocarriers: pharmacokinetics, efficacy and metabolomic analysis U Katragadda, W Fan, Y Wang, Q Teng, C Tan PloS one 8 (3), e58619, 2013 | 55 | 2013 |
| Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy X Xin, V Kumar, F Lin, V Kumar, R Bhattarai, VR Bhatt, C Tan, RI Mahato Science advances 6 (46), eabd6764, 2020 | 52 | 2020 |
| Efavirenz therapy in rhesus macaques infected with a chimera of simian immunodeficiency virus containing reverse transcriptase from human immunodeficiency virus type 1 MJ Hofman, J Higgins, TB Matthews, NC Pedersen, C Tan, RF Schinazi, ... Antimicrobial agents and chemotherapy 48 (9), 3483-3490, 2004 | 48 | 2004 |
| Pharmacokinetics and biodistribution of polymeric micelles containing miRNA and small-molecule drug in orthotopic pancreatic tumor-bearing mice V Kumar, V Mundra, Y Peng, Y Wang, C Tan, RI Mahato Theranostics 8 (15), 4033, 2018 | 45 | 2018 |
| Combination of rapamycin and 17-allylamino-17-demethoxygeldanamycin abrogates Akt activation and potentiates mTOR blockade in breast cancer cells MM Roforth, C Tan Anti-cancer drugs 19 (7), 681-688, 2008 | 45 | 2008 |
| Combined Delivery of Let-7b MicroRNA and Paclitaxel via Biodegradable Nanoassemblies for the Treatment of KRAS Mutant Cancer X Dai, W Fan, Y Wang, L Huang, Y Jiang, L Shi, DA Mckinley, W Tan, ... Molecular pharmaceutics 13 (2), 520-533, 2016 | 42 | 2016 |
